Publication of RGN-259 Phase 3 Clinical Trial Results in Patients with Neurotrophic Keratopathy
ROCKVILLE, Md., Jan. 3, 2023. RegeneRx Biopharmaceuticals, Inc. ( " RegeneRx " or " Company " ), a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting today a new scientific publication describing... (Source: - Clinical Trials)
Source: - Clinical Trials - January 3, 2023 Category: Pharmaceuticals Source Type: clinical trials

RESTORES Trial: RESToration Of Rehabilitative Function With Epidural Spinal Stimulation
Condition:   Chronic Spinal Cord Injury Intervention:   Device: RESToration Of Rehabilitative function with Epidural spinal Stimulation Sponsors:   National Neuroscience Institute;   Agency for Science, Technology and Research;   Tan Tock Seng Hospital Not yet recruiting (Source:
Source: - December 9, 2022 Category: Research Source Type: clinical trials

Network Neuro-modulation for Mesial Temporal Lobe Epilepsy
Condition:   Mesial Temporal Lobe Epilepsy Interventions:   Device: Low Frequency Stimulation (LFS) of site with the Medtronic Percept PC system;   Device: Standard of Care (SOC) High Frequency Stimulation of the Anterior Nucleus of the Thalamus (ANT) with the Medtronic Percept PC system Sponsors:   The University of Texas Health Science Center, Houston;   National Institute of Neurological Disorders and Stroke (NINDS) Not yet recruiting (Source:
Source: - November 8, 2022 Category: Research Source Type: clinical trials